Ultrasensitive amperometric saliva glucose sensor strip

• US 20080177166A1
• Filed: 03/07/2007
• Published: 07/24/2008
• Est. Priority Date: 01/18/2007
• Status: Abandoned Application

• Current Assignee: Promdx Technology Incorporated
• Original Assignee: Promdx Technology Incorporated
• Inventors: Pronovost, Allan D., Hickey, Michael
• Application Number:
  US11/715,719
• Publication Number:
  US 20080177166A1
• Time in Patent Office: Days
• US Class Current: 600/365
• CPC Class Codes: C12Q 1/006 for glucose

Abstract

Methods and apparatus for measuring a carbohydrate in a fluid are presented. An amperometric glucose sensor system suitable for glucose monitoring in a biological sample other than blood includes a support member having a sample region defined thereon in fluid communication with a measurement zone including an electrode having an exposed surface area. Biological sample fluid is transported from the sample region to the measurement zone, which includes an exposed catalyst in communication with the electrode providing a minimum sensitivity of at least about 50 micromolar glucose concentration and a noise level of less than about 0.5 nA/μM/mm². In some embodiments, at least one of a nanofiltration material and a porous absorbent material is provided between the sample region and the measurement zone.

Claims

1. An apparatus for detecting a concentration of glucose in a biological sample other than blood, comprising:

a support member;

an electrode disposed on the support member having an exposed surface area;

a sample region comprising a sample port upon which the biological sample is applied;

a lumen having a proximal end in fluid communication with the sample region; and

a measurement zone in fluid communication with a distal end of the lumen, the measurement zone having an enzymatic catalyst, the measurement zone providing a minimum sensitivity of at least about 50 micromolar glucose concentration and a noise level of less than about 0.5 nA/μ

M/mm².

2. The apparatus of claim 1, wherein the biological sample is saliva.

3. The apparatus of claim 1, wherein the electrode is a multi-layer electrode.

4. The apparatus of claim 3, wherein the multi-layer electrode comprises a platinized carbon electrode layer deposited on a plastic film layer.

5. The apparatus of claim 3, wherein the multi-layer electrode includes at least one metal selected from the group consisting of:

gold;

palladium;

carbonized platinum; and

platinum.

6. The apparatus of claim 3, wherein the multi-layer electrode includes a platinum layer over a titanium layer.

7. The apparatus of claim 6, wherein the plastic film comprises at least one of polyvinylidene difluoride (PVDP) and polyethylene terephthalate (PET) as a solid phase.

8. The apparatus of claim 1, wherein the enzymatic catalyst is glucose oxidase.

9. The apparatus of claim 8, wherein the glucose oxidase is present at a concentration of at least about 1 weight percent.

10. The apparatus of claim 1, wherein the support comprises one or more conductive coatings for forming at least three electrodes including a working electrode, a fill electrode, and a reference electrode.

11. The apparatus of claim 10 wherein the conductive coatings comprise at least one metal or metal salt selected from the group consisting of:

carbon, gold, palladium platinum, titanium, silver, and silver chloride.

12. The apparatus of claim 10, wherein the support further comprises one or more layers selected from the group consisting of:

a dielectric layer, a spacer layer and a lid layer.

13. The apparatus of claim 12, wherein the one or more layers are formed from a plastic selected from the group consisting of:

polyethylene terephthalate (PET), polyester, polycarbonate, polyvinyl chloride (PVC), polysulfone, acrylic and polystyrene.

14. The apparatus of claim 13, further comprising a filter for filtering the biological sample.

15. The apparatus of claim 14, wherein the filter comprises a nanofiltration material and a porous absorbent material.

16. The apparatus of claim 15, wherein the nanofiltration material is a hydrophilic nanopore membrane selected from the group consisting of:

ion track-etched polycarbonate nanomembranes;

inorganic aluminum oxide nanomembranes;

polyester nanomembranes; and

composite ceramic nanopore membranes.

17. The apparatus of claim 15, wherein the porous absorbent material is selected from the group consisting of:

a zeolite;

aluminum oxide microspheres;

ceramic microspheres;

hydrous alumina silicate microspheres;

alumina dessicant microbeads;

attapulgus clay beaded silica gel dessicants;

natural clay absorbents;

natural clay adsorbents;

activated carbon; and

combinations thereof.

18. The apparatus of claim 1, wherein the exposed surface area is at least about 10 mm².

19. The apparatus of claim 1, wherein the measurement zone provides a sensitivity from about 0 milligrams per deciliter glucose concentration to about 30 milligrams per deciliter glucose concentration.

20. An apparatus for processing a mammalian saliva sample comprising:

a saliva sample port for receiving the saliva sample; and

a filter in fluid communication with the sample port, the filter including;

a nanofiltration material configured to remove high molecular weight contaminants from the saliva sample; and

a porous absorbent material configured to absorb at least a portion of the saliva sample,

wherein the saliva sample is filtered by the nanofiltration material and the absorbent material.

21. The apparatus of claim 20, wherein the nanofiltration material comprises a hydrophilic nanopore membrane selected from the group consisting of:

ion track-etched polycarbonate nanomembranes;

inorganic aluminum oxide nanomembranes;

polyester nanomembranes;

composite ceramic nanopore membranes; and

combinations thereof.

22. The apparatus of claim 20, wherein the porous absorbent material has an internal surface area greater than about 400 M²/gram.

23. The apparatus of claim 20, wherein the porous absorbent material is selected from the group consisting of:

a zeolite;

aluminum oxide microspheres;

ceramic microspheres;

hydrous alumina silicate microspheres;

alumina dessicant microbeads;

attapulgus clay beaded silica gel dessicants;

natural clay absorbents;

natural clay adsorbents;

activated carbon; and

combinations thereof.

24. The apparatus of claim 20, further comprising a sensor in communication with the saliva sample absorbed into the matrix, the sensor detecting glucose levels in the processed saliva sample.

25. The apparatus of claim 24, wherein the sensor is an electrochemical sensor configured for determining a concentration of an analyte via an electrochemical oxidation and reduction reaction.

26. The apparatus of claim 25, wherein the electrochemical sensor comprises:

a rigid support member;

a metallic electrode disposed on the rigid support member having a surface area of at least about 10 mm²;

a sample region comprising a sample port upon which the biological sample is applied;

a lumen having a proximal end in fluid communication with the sample region; and

a measurement zone in fluid communication with a distal end of the lumen, the measurement zone having an enzymatic catalyst, the measurement zone providing a minimum sensitivity of at least about 50 micromolar glucose concentration and a noise level of less than about 0.5 nA/μ

M/mm².

27. A method for determining glucose levels in a mammalian saliva sample comprising:

receiving the saliva sample at a sample port;

transporting at least a portion of the received saliva sample from the sample port to a measurement zone;

combining the transported saliva sample with an enzymatic catalyst within the measurement zone;

measuring a glucose level of the saliva sample with a minimum sensitivity of at least about 50 micromolar glucose concentration and a noise level of less than about 0.5 nA/μ

M/mm².

28. The method of claim 27, wherein the enzymatic catalyst is glucose oxidase.

29. The method of claim 28, wherein the glucose oxidase is present at a concentration of at least about 1 weight percent.

30. The method of claim 27, further comprising filtering the saliva sample using at least one of a nanofiltration material and a porous absorbent material.

31. The method of claim 27, further comprising filtering the saliva sample using a nanofiltration material and a porous absorbent material.

32. The method of claim 31, wherein the nanofiltration material is a hydrophilic nanopore membrane selected from the group consisting of:

ion track-etched polycarbonate nanomembranes;

inorganic aluminum oxide nanomembranes;

polyester nanomembranes; and

composite ceramic nanopore membranes.

33. The method of claim 31, wherein the porous absorbent material is selected from the group consisting of:

a zeolite;

aluminum oxide microspheres;

ceramic microspheres;

hydrous alumina silicate microspheres;

alumina dessicant microbeads;

attapulgus clay beaded silica gel dessicants;

natural clay absorbents;

natural clay adsorbents;

activated carbon; and

combinations thereof.

34. The method of claim 27, wherein the measurement zone provides a sensitivity from about 0 milligrams per deciliter glucose concentration to about 30 milligrams per deciliter glucose concentration.